Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • EU leaders host Zelenskiy in Brussels, pledging support and winter preparations for Ukraine.
  • President Trump called Ukrainian strikes on Russian refineries 'a disgrace' and signaled potential cuts to U.S. intelligence and weapons support.
  • Attacks caused civilian casualties and disrupted energy supplies, increasing regional energy market risk.
  • Ukraine pressed partners for additional funding to sustain defenses ahead of winter.
  • CHEF hit a 52-week high after an earnings beat; analysts recommend a tactical buy with stop-loss protection.
  • Monro completed restructuring, yields about 7.8% and offers roughly 30% upside, but faces liquidity and heavy short-interest risks.

Latest Articles

WeShop to Launch in the U.S. November 16: Community-Owned Shopping App Puts Consumers at the Center of a New Model Built Around Rewards, Participation and Ownership
Sep 29, 2026
Avery Klein
Press Releases

WeShop to Launch in the U.S. November 16: Community-Owned Shopping App Puts Consumers at the Center of a New Model Built Around Rewards, Participation and Ownership

WeShop Holdings Limited (NASDAQ: WSHP), a community-owned shopping platform, announced the launch of its free app in the United States on November 16, 2026. Building on a successful UK pilot that generated £108.5 million in GMV, the app allows members to shop with hundreds of retailers, earn ShareBack rewards in the form of equity, and build owners…

WSHP
argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline
Sep 29, 2026
Ajmal Hussain
Press Releases

argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

argenx SE announced new clinical, long-term, and real-world evidence data on its lead drug VYVGART for treating myasthenia gravis (MG) and chronic inflammatory demyelinating polyneuropathy (CIDP), along with promising results for pipeline drugs empasiprubart and adimanebart. The data show sustained efficacy, safety, and benefits of earlier treatmen…

ARGX
IMUNON Converts $1.2 Million of Debt-to-Equity
Sep 29, 2026
Jordan Park
Press Releases

IMUNON Converts $1.2 Million of Debt-to-Equity

IMUNON, Inc., a clinical-stage biotechnology firm, completed an exchange agreement converting $1.2 million of outstanding debt into Series B Preferred Stock, reducing debt by approximately 43% and increasing shareholders' equity. The transaction was done without issuing common stock or dilutive warrants, preserving financial flexibility and minimiz…

IMNN
HUHUTECH Expects Two Japan Projects with Estimated Aggregate Value of Approximately $12 Million to Advance Toward Contracting in Q4 2026
Sep 29, 2026
Caleb Monroe
Press Releases

HUHUTECH Expects Two Japan Projects with Estimated Aggregate Value of Approximately $12 Million to Advance Toward Contracting in Q4 2026

HUHUTECH International Group Inc. expects two key projects in Japan, valued at approximately $12 million, to advance toward contracting in Q4 2026. These projects, involving power system engineering and heated piping system integration, would begin execution in mid-2027 and continue through 2028. The developments underscore the company's continued …

HUHU
EagleNXT Participates in Michigan NADWC DDIL Testing Environment Supporting Army Permissive Range Initiative
Sep 29, 2026
Caleb Monroe
Press Releases

EagleNXT Participates in Michigan NADWC DDIL Testing Environment Supporting Army Permissive Range Initiative

AgEagle Aerial Systems Inc. (EagleNXT) successfully demonstrated its newly developed anti-jamming technology for drones in the Denied, Disrupted, Intermittent and Limited (DDIL) environment at Michigan's National All-Domain Warfighting Center. The technology showed strong performance in realistic contested conditions, supporting the U.S. Army's Per…

UAVS
Diginex (NASDAQ: DGNX) Launches Enhanced End-to-End Supply Chain Platform Targeting $7+ Billion Market by 2029, Growing at 29% CAGR
Sep 29, 2026
Caleb Monroe
Press Releases

Diginex (NASDAQ: DGNX) Launches Enhanced End-to-End Supply Chain Platform Targeting $7+ Billion Market by 2029, Growing at 29% CAGR

Diginex Limited (NASDAQ: DGNX) announced the launch of an enhanced end-to-end supply chain due diligence platform designed to provide companies with comprehensive visibility across multiple supplier tiers. This platform aims to help firms identify and mitigate risks, lower operating costs, reduce litigation exposures, and comply with evolving regul…

DGNX
Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs
Sep 29, 2026
Derek Hwang
Press Releases

Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs

WW International, Inc. announces a strategic collaboration with Google Health Enterprise to enhance its weight management program through integration with Google's Fitbit Air wearable and AI-powered insights. The partnership aims to increase engagement and improve outcomes by offering personalized tracking of activity, sleep, and health signals to …

WW
Provident Bank Survey: 7 in 10 Americans Are Rethinking Higher Education, and Nearly 1 in 3 Are Eyeing the Alternatives
Sep 29, 2026
Leila Farooq
Press Releases

Provident Bank Survey: 7 in 10 Americans Are Rethinking Higher Education, and Nearly 1 in 3 Are Eyeing the Alternatives

Provident Bank's 2026 Higher Education Survey shows nearly 70% of Americans are rethinking the financial value of traditional higher education amid rising costs, with increasing consideration for trade and technical schools as viable alternatives. The survey highlights gaps in education savings and a significant opportunity for banks to provide bet…

PFS
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
Sep 29, 2026
Ajmal Hussain
Press Releases

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

NewAmsterdam Pharma has dosed the first participant in its Phase 2b SPINOZA clinical trial evaluating obicetrapib, a novel oral CETP inhibitor, in adults with biomarker evidence of preclinical Alzheimer's disease. The trial involves approximately 400 patients with specific ApoE genotypes and aims to assess changes in Alzheimer's disease biomarkers …

NAMS
Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD
Sep 29, 2026
Nina Shah
Press Releases

Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD

Phathom Pharmaceuticals announced the initiation of a registrational Phase 3 study (pHalcon-NERD-302) to evaluate VOQUEZNA (vonoprazan) as an as-needed treatment for Non-Erosive GERD (NERD). Building on positive Phase 2 data, this study aims to assess the efficacy and safety of VOQUEZNA in providing rapid and sustained relief of heartburn episodes.…

PHAT
Tokyo Lifestyle Co., Ltd. Strengthens Capital Structure Through Cash Investment and Debt-to-Equity Conversion
Sep 29, 2026
Priya Menon
Press Releases

Tokyo Lifestyle Co., Ltd. Strengthens Capital Structure Through Cash Investment and Debt-to-Equity Conversion

Tokyo Lifestyle Co., Ltd. announced two key equity transactions approved by its board aimed at strengthening the company's capital structure. The Representative Director made a direct cash investment of approximately US$0.38 million, while an affiliated entity converted JPY510 million (approx. US$3.32 million) of outstanding shareholder-related deb…

TKLF
SaverOne Awarded U.S. Patent for Automated Sensor Fusion Calibration and Maintenance: Strengthening its IP Protection as Fleet Deployments Scale
Sep 29, 2026
Leila Farooq
Press Releases

SaverOne Awarded U.S. Patent for Automated Sensor Fusion Calibration and Maintenance: Strengthening its IP Protection as Fleet Deployments Scale

SaverOne has been awarded a new U.S. patent for its advanced sensor fusion-based calibration and maintenance technology for its Phone Location Unit (PLU). This innovation allows the system to self-calibrate and maintain full operational accuracy over the vehicle's lifecycle, supporting efficient remote servicing at fleet scale. The patent strengthe…

SVRE
Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron
Sep 29, 2026
Leila Farooq
Press Releases

Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron

Nasus Pharma has enrolled and dosed its first patient in the Phase 1 pharmacokinetic study of NS003, an intranasal powder formulation of ondansetron aimed at treating chemotherapy-induced and post-operative nausea and vomiting. Preclinical data showed NS003's pharmacokinetic profile comparable to IV ondansetron with a favorable safety profile. The …

NSRX
Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting
Sep 29, 2026
Jordan Park
Press Releases

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting

Dianthus Therapeutics announced scheduled oral and poster presentations at the 2026 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting, showcasing encouraging Phase 2 and Phase 3 data for claseprubart, their investigational monoclonal antibody targeting autoimmune diseases such as generalized myasthenia grav…

DNTH
One and One Green Technologies Reports First Half 2026 Results
Sep 29, 2026
Derek Hwang
Press Releases

One and One Green Technologies Reports First Half 2026 Results

One and One Green Technologies, Inc. announced financial results for the first half of 2026, reporting an 18.7% increase in revenue to $33.4 million and a 17.4% rise in net income to $4.5 million. Growth was fueled by a 39% increase in copper alloy ingot revenue due to stronger demand in Asia-Pacific and capacity reallocation, despite a temporary s…

YDDL
Microchip Expands Single Pair Ethernet Portfolio with New 10BASE‑T1S Devices Enabling Scalable Edge Connectivity
Sep 29, 2026
Nina Shah
Press Releases

Microchip Expands Single Pair Ethernet Portfolio with New 10BASE‑T1S Devices Enabling Scalable Edge Connectivity

Microchip Technology expands its Single Pair Ethernet portfolio with the launch of LAN8679 and LAN8680 10BASE-T1S PMD transceivers and the LAN8660X/1X/2X integrated endpoint family. These devices enable flexible, space-efficient, and reliable Ethernet connectivity for next-generation zonal architectures across automotive, industrial, robotics, aero…

MCHP